NDC 0944-5001

OBIZUR

Antihemophilic Factor (recombinant), Porcine Sequence

OBIZUR is a Kit in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is .

Product ID0944-5001_1035bf89-ce7c-4986-b4f1-5b44c2ce0be0
NDC0944-5001
Product TypePlasma Derivative
Proprietary NameOBIZUR
Generic NameAntihemophilic Factor (recombinant), Porcine Sequence
Dosage FormKit
Marketing Start Date2014-10-23
Marketing CategoryBLA / BLA
Application NumberBLA125512
Labeler NameBaxalta US Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0944-5001-01

1 KIT in 1 CARTON (0944-5001-01) * 1 mL in 1 VIAL, GLASS (0944-5011-01) * 1 mL in 1 SYRINGE, GLASS (0944-0011-01)
Marketing Start Date2014-10-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0944-5001-01 [00944500101]

OBIZUR KIT
Marketing CategoryBLA
Application NumberBLA125512
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2014-10-23

NDC 0944-5001-10 [00944500110]

OBIZUR KIT
Marketing CategoryBLA
Application NumberBLA125512
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2014-10-23

NDC 0944-5001-05 [00944500105]

OBIZUR KIT
Marketing CategoryBLA
Application NumberBLA125512
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2014-10-23

Drug Details


Trademark Results [OBIZUR]

Mark Image

Registration | Serial
Company
Trademark
Application Date
OBIZUR
OBIZUR
86097604 4721052 Live/Registered
BAXALTA INCORPORATED
2013-10-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.